scholarly journals Impact of labor induction at 39 weeks gestation compared with expectant management on maternal and perinatal morbidity among a cohort of low-risk women

Author(s):  
Sabrina C. Burn ◽  
Ruofan Yao ◽  
Maria Diaz ◽  
Jordan Rossi ◽  
Stephen Contag
2021 ◽  
Author(s):  
Sabrina C. Burn ◽  
Ruofan Yao ◽  
Maria Diaz ◽  
Jordan Rossi ◽  
Stephen Contag

Abstract Objective: To determine rates of maternal and perinatal outcomes after induction of labor (IOL) at 39 weeks compared with expectant management.Methods: Cohort study of low risk women delivered between 39-42 weeks from 2015 to 2018. We excluded births with fetal abnormalities, previous cesarean, multiple pregnancies or those with spontaneous onset of labor (SOL) or indicated delivery at 39 weeks. Data was abstracted from National Center for Health Statistics birth files. Relative risks (aRR) were estimated with multivariable log-binomial regression. Main Outcome Measures: Maternal outcomes: chorioamnionitis (Triple I), blood transfusion, neonatal intensive care unit (NICU) admission, uterine rupture, cesarean delivery and cesarean hysterectomy. Fetal and infant outcomes: fetal death, 5-minute Apgar ≤3, prolonged ventilation, seizures, ICU admission, and death within 28 days. Results: There were 15,900,956 births, with 8,540,063 after exclusions. The IOL group included 1,177,790 births excluding women with diabetes or hypertensive disease. There were 3,835,185 births after 39 weeks excluding women with diabetes or chronic hypertension. With IOL at 39 weeks the risk for blood transfusion (p-value < 0.01; aRR 0.78; 95% CI [0.75-0.82]), Triple I (p-value < 0.01; aRR 0.71; 95% CI [0.70-0.73]) and cesarean delivery (p-value <0.01; aRR 0.87; 95% CI [0.87-0.88]) were lower, albeit increased risk of cesarean hysterectomy (p-value <0.01; aRR 1.23; 95% CI [1.07-1.41]). Neonates had a lower risk for 5-minute Apgar ≤3 (p-value < 0.01; aRR 0.68; 95% CI [0.66-0.71]), prolonged ventilation (p-value < 0.01; aRR 0.84; 95% CI [0.81-0.87]), NICU admission (p-value < 0.01; aRR 0.86; 95% CI [0.85-0.87]), and neonatal seizures (p-value <0.01; aRR 0.85; 95% CI [0.76-0.96]). There was no difference in risk for neonatal death 0.99% (p-value 0.99; aRR 1.00; 95%CI [0.99-1.00]), or fetal death (p-value 0.78; aRR 1.0002; 95%CI [0.99-1.002]. This benefit was greater compared with each subsequent week.Conclusions: Induction of labor at 39 weeks of gestation in a low risk cohort is associated a lower risk of cesarean delivery, transfusions and infection, as well as lower neonatal morbidity, without difference in fetal or neonatal death. This appears to be associated with increased risk for cesarean hysterectomy.


2016 ◽  
Vol 6 (3) ◽  
pp. 173-182 ◽  
Author(s):  
Suze M. P. J. Jans ◽  
Kathy C. Herschderfer ◽  
Mariet Th. van Diem ◽  
Mieke Aitink ◽  
Marlies Rijnders ◽  
...  

PURPOSE:To test third stage management of labor for low-risk women comparing routine prophylactic intramuscular oxytocin management versus modified expectant management.STUDY DESIGN:Randomized controlled multicenter trial in primary care midwifery practice.MAJOR FINDINGS:32.4% of women in the prophylactic intramuscular oxytocin management group had blood loss of 500 mL or more versus 44.2% in the modified expectant management group, relative risk (RR) 0.61, 95% confidence interval (CI) [0.50, 0.74]. The percentage of women experiencing postpartum hemorrhage (PPH) defined as more than 1,000 mL blood loss was 6.3% in the prophylactic intramuscular oxytocin management group versus 11.9% in the modified expectant management group (RR 0.50, 95% CI [0.36, 0.71]). The type of management showed no significant differences between the two groups in clinically relevant indicators of women’s short-term health such as the number of referrals, treatment given, hemoglobin level 36 hours postpartum, and breastfeeding rates after 1 week. Medium-term health such as hemoglobin level at 6 weeks postpartum, women’s perceptions of tiredness, and breastfeeding rates at 3 months after birth also showed no differences between the two groups.CONCLUSION:Third stage management by means of routine prophylactic intramuscular oxytocin reduced the risk of postpartum hemorrhage in a group of childbearing women at low risk of complications in primary midwifery care compared to modified expectant third stage management, but there was no evidence this was associated with a reduction in clinically relevant adverse health outcomes.


2012 ◽  
Vol 207 (6) ◽  
pp. 502.e1-502.e8 ◽  
Author(s):  
Yvonne W. Cheng ◽  
Anjali J. Kaimal ◽  
Jonathan M. Snowden ◽  
James M. Nicholson ◽  
Aaron B. Caughey

2018 ◽  
Vol 379 (6) ◽  
pp. 513-523 ◽  
Author(s):  
William A. Grobman ◽  
Madeline M. Rice ◽  
Uma M. Reddy ◽  
Alan T.N. Tita ◽  
Robert M. Silver ◽  
...  

Author(s):  
Stephen M. Wagner ◽  
Grecio Sandoval ◽  
William A. Grobman ◽  
Jennifer L. Bailit ◽  
Ronald J. Wapner ◽  
...  

Objective Our objective was to compare outcomes among low-risk parous women who underwent elective labor induction at 39 weeks versus expectant management. Study Design This is a secondary analysis of an observational cohort of 115,502 mother–infant dyads who delivered at 25 hospitals between 2008 and 2011. The inclusion criteria for this analysis were low-risk parous women with nonanomalous singletons with at least one prior vaginal delivery after 20 weeks, who delivered at ≥390/7 weeks. Women who electively induced between 390/7 and 396/7 weeks were compared with women who expectantly managed ≥390/7 weeks. The primary outcome for this analysis was cesarean delivery. Secondary outcomes were composites of maternal adverse outcome and neonatal adverse outcome. Multivariable logistic regression was used to estimate adjusted odds ratios (aOR). Results Of 20,822 women who met inclusion criteria, 2,648 (12.7%) were electively induced at 39 weeks. Cesarean delivery was lower among women who underwent elective induction at 39 weeks than those who did not (2.4 vs. 4.6%, adjusted odds ratio [aOR]: 0.70, 95% confidence interval [CI]: 0.53–0.92). The frequency of the composite maternal adverse outcome was significantly lower for the elective induction cohort as well (1.6 vs. 3.1%, aOR: 0.66, 95% CI: 0.47–0.93). The composite neonatal adverse outcome was not significantly different between the two groups (0.3 vs. 0.6%; aOR: 0.60, 95% CI: 0.29–1.23). Conclusion In low-risk parous women, elective induction of labor at 39 weeks was associated with decreased odds of cesarean delivery and maternal morbidity, without an increase in neonatal adverse outcomes. Key Points


2019 ◽  
Vol 74 (1) ◽  
pp. 7-9
Author(s):  
William A. Grobman ◽  
Madeline M. Rice ◽  
Uma M. Reddy ◽  
Alan T. N. Tita ◽  
Robert M. Silver ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document